Global Statistics

All countries
595,168,628
Confirmed
Updated on August 15, 2022 2:15 am
All countries
566,803,948
Recovered
Updated on August 15, 2022 2:15 am
All countries
6,454,572
Deaths
Updated on August 15, 2022 2:15 am

Global Statistics

All countries
595,168,628
Confirmed
Updated on August 15, 2022 2:15 am
All countries
566,803,948
Recovered
Updated on August 15, 2022 2:15 am
All countries
6,454,572
Deaths
Updated on August 15, 2022 2:15 am
- Advertisment -

When Will Vaccine Be Ready For Covid 19

Will Masterlisting Be Done Online How Will Those Without Access To The Internet Be Included

Health facilities and LGUs may submit required data online through VIMS-IR, any information system linked to VIMS-IR, or physical forms for areas without connectivity. The forms are to be consolidated by the Human Resource Office of the facility and submitted to LGUs for encoding and submission to CHDs.

How Long Will Vaccine Immunity Last

We are still learning how long immunity lasts after infection or vaccination. The latest information shows that:

  • Following infection people are not likely to be re-infected within 90 days of infection. However, they are working to learn more about immunity following infection. While some people have been re-infected after recovering from COVID-19, the number of people who have experienced this is small compared with the total number of people who have been infected.
  • Following vaccination with the mRNA vaccines, people are immune for at least 6 months and likely much longer. The same is likely to be true for the adenovirus-based vaccines too, but we are still waiting for data. Based on the elements of the immune response activated after vaccination with either the mRNA or adenovirus vaccines, it is likely that immunity will be long-lived. But time will tell, and if the virus changes in a way that evades immunity generated by vaccination, that would also affect the duration of protection.

What Is The Required Age For Vaccination

This will depend on the vaccine. For those currently available, Sinovac can be given to clinically healthy individuals 18 to 59 years old, while AstraZeneca can be given to those 18 years old and above, including senior citizens.

DOH shall develop a Department Memorandum for every COVID vaccine to be deployed in the country and this DM shall indicate the target or recommended age groups per vaccine.

Will Annual Or Booster Doses Of Covid

We are still not certain whether people will need to get additional doses of the COVID-19 vaccine because we are still learning how long immunity lasts after:

  • Illness
  • Vaccination

Further, the increased presence of variants might affect whether or how often additional doses would be needed. This is one reason scientists are anxious to get as many people vaccinated as possible the more the virus can replicate in people, the greater the chance that it will change in a way that allows it to spread widely even among people who have been vaccinated. With this in mind, scientists are continuing to monitor variants and the ability of currently available vaccines to protect against them.

Why Will The Prioritized Groups Get The Vaccine First

Until a coronavirus vaccine is ready, pneumonia vaccines ...

With the initial limited supply, frontline health workers and uniformed personnel are prioritized since they have higher risk of exposure while on duty and to allow them to continue fulfilling their duties in both the public and private sectors. Vulnerable groups such as the elderly and the indigent population, are prioritized guided by the principle of equity.

If My Baby Has Had Some Of Her Vaccines Is She Protected From Covid

A babys vaccines should not be anticipated to protect the baby from COVID-19. So, when trying to decide when it may be safe for family to meet the baby during COVID, parents should not rely on other vaccinations as a source of protection. While some have hypothesized that other vaccines may be protective, this protection would not be specific to COVID-19, and no studies have actually been completed to test this theory.

If I Am Taking Anticoagulants Can I Get The Covid

Patients on blood thinners are asked to speak with a healthcare provider because the vaccine is given intramuscularly, which increases the risk for bleeding. The vaccine itself does not increase the risk for this group of patients.

Find out more in this Parents PACK article, “Medications and COVID-19 Vaccines: What You Should Know.”

If I Am Taking Antivirals Can I Get The Covid

You do not need to stop taking antiviral medication before vaccination. Because the mRNA and adenovirus-based vaccines does not rely on viral replication, antivirals should not affect development of the immune response. However, if you are still experiencing symptoms of the infection for which the antivirals were prescribed, you should wait until you are feeling better before getting the vaccine.

Find out more in this Parents PACK article, “Medications and COVID-19 Vaccines: What You Should Know.”

Can I Get The Covid

In the U.S., the CDC recommends waiting until COVID-19 symptoms go away and the individual is done . However, they indicate that it is okay to get the COVID-19 vaccine shortly after recovering from the disease as long as the patient was not treated with antibody-based treatments .

Due to limited supplies of vaccine in some countries and the experience that people who recently had COVID-19 rarely get re-infected in the months immediately after recovery, some areas may be delaying vaccination of recently recovered individuals. As such, we recommend talking with your healthcare provider or health officials to see what the recommendations are in your area.

What Is The Status Of Covid

Phase 3 studies are underway for the Moderna and BioNTech/Pfizer vaccines, the Oxford/AstraZeneca viral vector vaccine and now the Johnson & Johnson viral vector vaccine.

Each of these vaccines uses the SARS-CoV-2 spike glycoprotein, which the virus uses to infect cells, to trigger the immune system to generate protective antibodies and a cellular immune response to the virus. Protective antibodies act by preventing the spike glycoprotein from attaching the virus to human cells, thereby neutralizing the SARS-CoV-2 virus that causes COVID-19.

In the case of Modernas nucleic acid vaccine, the messenger RNA encoding the spike glycoprotein is encased in a fat droplet called a liposome to protect the mRNA from degradation and enable it to enter cells. Once these instructions are inside the cells, the mRNA is read by the human cell machinery and made into many spike proteins so that the immune system can respond and begin producing antibodies against this coronavirus.

The Oxford/AstraZeneca and Johnson & Johnson vaccines use a different strategy to activate an immune response. Here an adenovirus found in chimpanzees shuttles the instructions for manufacturing the spike glycoprotein into cells.

Phase 1 and 2 studies by pharmaceutical companies Janssen and Merck also use viral vectors similar to the Oxford/AstraZeneca and J&J vaccines, while vaccines by Novavax and GSK-Sanofi use the actual spike protein itself.

Is There Risk Of Allergic Reaction From Covid

According to the CDC, anyone who has a known severe allergy to any of the vaccine ingredients should not receive that vaccine.

The CDC says people with allergies to certain foods, insects, latex and other common allergens can safely receive the COVID-19 vaccine. Those with a history of severe allergic reaction to injectables or other vaccines should discuss the vaccination with their doctor, who can evaluate and assess their risk.

How Do We Know a COVID-19 Vaccine Will Be Safe and Effective?

Is It Good To Have More Than One Vaccine Available

Absolutely. In fact, its highly desirable, says William Schaffner, an infectious disease expert and professor at Vanderbilt University School of Medicine, because that would mean there would be more vaccine manufacturers working to actually produce the vaccine, and so we could more expeditiously try to vaccinate the population in the United States and beyond.

Kathleen Neuzil, M.D., professor in vaccinology and director of the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, echoes Schaffners sentiment and points to the flu vaccine for comparison: There are multiple formulations on the market, including the injectable high-dose vaccine and the nasal spray vaccine, for example, which are recommended for different populations.

We really need every person on Earth, theoretically, to be able to receive this vaccine. So, to me, is a positive, because we need so much, she adds.

Editors note: This article, originally published May 1, 2020, has been updated to reflect new information.

Also of Interest

Do I Still Have To Wear A Mask And Continue Covid

Trump Claims COVID

The CDC continues to monitor the spread of COVID-19 and makes recommendations for wearing face masks, both for those who are fully vaccinated as well as those who are not fully vaccinated.

The CDC also recommends that masks and physical distancing are required when going to the doctors office, hospitals or long-term care facilities, including all Johns Hopkins hospitals, care centers and offices.

Johns Hopkins Medicines current mask safety guidelines have not changed, and we still require all individuals to wear masks inside all of our facilities.

Is The Oxford Vaccine Safe

A number of European countries suspended, then resumed, use of the Oxford-AstraZeneca vaccine in recent months. Prompted by a small number of blood clots in people who had received the vaccine, Denmark was the first country to pause its use of the vaccine. It was followed by Norway, Iceland, Germany, France, Ireland, Italy, Cyprus, Spain, Latvia and Sweden. Other countries have suspended use of specific batches.

Investigations by regulators in the UK and EU have concluded that, while its not conclusive, there is mounting evidence of a link between the vaccine and extremely rare blood clots.

It has prompted the UK to change course on its vaccination programme, with under-40s now being offered an alternative to the Oxford-AstraZeneca jab. The European Medicines Agency, meanwhile, doesnt recommend restricting the vaccine, although it has said that recipients should be warned of potential side effects, just as they would with other medicines.

Both regulators have stressed that the vaccine is safe for the majority of people, and that the benefits outweigh the risks. Its estimated that four in a million people can experience the side effects.

Up to the end of April, there had been 209 cases of blood clots in the UK and 41 deaths. Thats against more than 20m vaccines administered. Women seem to be more at risk, and there is also a slightly higher risk in young people. However, the risk of developing a blood clot across all ages is higher if you develop COVID-19.

What Are Cvst And Thrombocytopenia

Cerebral venous sinus thrombosis is a condition that causes blood clots in large vessels that drain blood from the brain. Although it is uncommon, the condition more often affects women between 20 and 50 years of age.

Thrombocytopenia is low numbers of cells called platelets. Platelets are cells that help our blood clot. When a person has this condition, they are at risk for bleeding since their body lacks the ability to efficiently stop the bleeding.

It is very uncommon for CVST and thrombocytopenia to occur at the same time, which is what makes this diagnosis following receipt of the J&J vaccine so unusual. Likewise, the clots have not just occurred in the large vessels near the brain in some of the affected individuals.

In Particular Vaccine Researchers Are Studying The Best Dosage For Each Age Group

In all of the clinical trials above, the vaccines are identical to the versions that adults receive, but theyre given at kid-sized doses. To determine the best dosage, clinical trials are broken into age groups for different stages of a childs growth and development.

For example, Pfizer is running separate trials for its COVID-19 vaccine in ages 5 to 11, ages 2 to under 5, and ages 6 months to under 2 years. All age groups are receiving the same vaccine, but the size of the dose might be different. Typically, the younger the age group, the smaller the dose.

Can I Get The Second Dose Of Covid

Yes. It is okay to get the second dose in the other arm as the immunity generated by the first dose will be circulating in your body watching for a potential exposure.

Indeed, individuals who experience a delayed reaction at the injection site are recommended to get the second dose in the opposite arm.

How The Us Vaccine Rollout Looks Right Now

Some seven months into the U.S. COVID-19 vaccine rollout, 51.9% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna drugs or a single injection of the one-dose Johnson & Johnson/Janssen version. Including “initial doses”those who have received only the first dose of Pfizer or Modernathe figure stands at 58.3%.

Now that the U.S. Food and Drug Administration has approved the Pfizer vaccine for 12- to 15-year-olds, the new pool of recipients may push national figures for new vaccine administrations back upward after a decline since peaking in mid-April. The interactive maps and charts below are updated daily to track the progress of both the shipment of shots in the U.S. and the success in getting them into patients arms.

While a few smaller states say they have administered virtually all of the first doses they have received from the federal government, there remains a nationwide gap between the reported number of surplus doses and ground-level reports of mass shortages. While the Department of Health and Human Services releases weekly figures on vaccine allocations and shipments to every state, territory, and a handful of federal programs, these maps use Centers for Disease Control and Prevention figures to show how many of those doses have arrived on site each day.

Will The Vaccines Work Against The New Emerging Variants

Several major coronavirus variants have identified in recent weeks and months. Originally known by their association with the country or region where they first developed, the World Health Organisation later These include:

  • The UK coronavirus variant. A study has shown the Pfizer vaccine appears to protect against this variant, however, the results have not yet been . Plus, the yet-to-be-approved Novavax vaccine has shown an 89 per cent efficacy in large-scale UK trials.
  • The South Africa coronavirus variant . A study from Pfizer has indicated their vaccine is effective against this strain. However, these findings have not yet been peer-reviewed. The Novavax vaccine is also believed to highly effective against it.
  • The Brazil coronavirus variant. No large scale trials have yet emerged examining vaccine efficacy against the this variant of the virus, but a small study has indicated the Pfizer vaccine protects against the UK, Brazil and South Africa strains.
  • The Indian coronavirus variant. Initial studies have found that the Pfizer, AstraZeneca and Novavax vaccines are effective against this highly transmissible variant after two doses. However, the jabs are only 33 per cent effective three weeks after a single dose. That compares to 50 per cent effectiveness against the UK variant. The variant is believed to be 40 per cent more transmissible than the Alpha variant.

Read more:

Vaccine Clinical Trial Process

Phase one: Checks the safety of a vaccine and determines whether it triggers an immune response in a small group of healthy humans. 

Phase two: Widens the testing pool to include groups of people who may have the disease or be more likely to catch it, to gauge the vaccines effectiveness. 

Phase three: Expands the pool up to the thousands to make sure the vaccine is safe and effective among a wider array of people, given that immune response can vary by age, ethnicity, or by underlying health conditions.

The COVID-19 candidates, like all vaccines, essentially aim to instruct the immune system to mount a defense, which is sometimes stronger than what would be provided through natural infection and with fewer health consequences.

To do so, traditional vaccines use the whole coronavirus, but in a killed or weakened state. Others use only part of the viruswhether a protein or a fragment. Some transfer the instructions for coronavirus proteins into an unrelated virus that is unlikely or even incapable of causing disease. Finally, cutting-edge vaccines under development rely on deploying pieces of the coronaviruss genetic material, enabling our cells to temporarily make coronavirus proteins needed to stimulate our immune systems.

Is It Safe To Get The Covid

When will a COVID

The CDC recommends waiting until your symptoms go away and you are no longer isolating. If you happen to be infected, but dont know because you have not yet developed symptoms or you have an infection without symptoms, the vaccine is not likely to be harmful. It would increase your bodys immune response against the virus.

Why Is It Necessary To Create And Maintain A Masterlist

To prepare the country for the COVID-19 vaccination program, a masterlist will: provide basis for identification of target eligible groups for vaccination and identification of priority areas for registration of eligible individuals; ensure uniqueness of individuals in the vaccine administration plan; and provide input to operational planning especially for costing and allocation of resources.

To prepare the country for the COVID-19 vaccination program, a masterlist will: provide basis for identification of target eligible groups for vaccination and identification of priority areas for registration of eligible individuals; ensure uniqueness of individuals in the vaccine administration plan; and provide input to operational planning especially for costing and allocation of resources.

How Are Vaccines Developed

The development of a vaccine against COVID-19 has taken place in an unparalleled pace. Usually such a process takes years, but the scope of the pandemic triggered round-the-clock work by thousands of researchers working on over 100 different forms of the vaccine.

Effectiveness and safety were key concerns and the Pfizer vaccine approved in the U.S. for emergency use has been found to have 95% efficacy after its second dose.

Before any  can be used widely, it must go through development and testing to make sure that its effective against the virus or bacteria and that it doesnt cause other problems. The stages of development generally follow this timeline:

Continued

Is A Coronavirus Vaccine Necessary

SARS-CoV-2 infections can be a minor hindrance or lead to severe disease or even death. While hygiene measures such as social distancing, handwashing, and wearing masks offer some help, the best way to stop this virus is to generate SARS-CoV-2-specific immunity. No virus has ever eliminated itself by inducing natural immunity in a large percentage of the population. Only herd immunity induced by vaccination can eliminate viruses, as has now been shown for smallpox and two of the three different types of poliovirus.

When Will The Covid

Juan C. Salazar, MD, MPH, FAAP

The FDA has granted emergency use authorization to three  vaccines, and more than 300 million doses have been administered across the U.S. This is a huge step in our fight to end the pandemic. 

We know that many families are eager to hear what happens next.

Connecticut Childrens Physician-in-Chief Juan Salazar, MD, MPH, shares what we know so far.

Are They All Equally Effective

It is hard to compare one company’s results with another as their trials will have been conducted in slightly different ways and at different points in the pandemic.

However, all the main vaccines seem to have a large impact on your chances of needing hospital treatment or dying from Covid.

Nonetheless, one of the most important questions – do they stop you spreading the virus – remains unknown.

Understanding which method produces the best results will be explored in challenge trials where people are deliberately infected with the virus.

Questions And Answers About Covid

On this page, you will find answers to some of the most common questions people are asking about COVID-19 disease and vaccines. Just click on the question of interest and the answer will appear below it. 

Can’t find what you’re looking for?

You can also find information related to COVID-19 on our printable Q&A, “COVID-19 mRNA vaccines: What you should know”  and our Look at Each Vaccine: COVID-19 Vaccine webpage.

July 29, 2021:Wondering how the mRNA vaccines are processed? Check out our newly released animation, How mRNA Vaccines Work.

Other Myths And Facts

No. The federal government does not mandate vaccination for people. Additionally, CDC does not maintain or monitor a persons vaccination records. Whether a state or local government or , for example, can require or mandate COVID-19 vaccination is a matter of state or other applicable lawexternal icon.

No. None of the authorized COVID-19 vaccines in the United States contain the live virus that causes COVID-19. This means that a COVID-19 vaccine cannot make you sick with COVID-19.

COVID-19 vaccines teach our immune systems how to recognize and fight the virus that causes COVID-19. Sometimes this process can cause symptoms, such as fever. These symptoms are normal and are signs that the body is building protection against the virus that causes COVID-19. Learn more about how COVID-19 vaccines work.

No. Your menstrual cycle cannot be affected by being near someone who received a COVID-19 vaccine.

Many things can affect menstrual cycles, including stress, changes in your schedule, problems with sleep, and changes in diet or exercise. Infections may also affect menstrual cycles.

What If I Cant Get The Second Dose 21 Or 28 Days After The First Dose

Work To Be Done Before People Feel Ready For COVID

The Centers for Disease Control and Prevention allows for a 4-day grace period when assessing on-time receipt. This means the following ranges of days are considered on-time for receipt of the second dose:

  • Pfizer vaccine: 17 to 25 days after the first dose
  • Moderna vaccine: 24 to 32 days after the first dose

People should try to get the second dose during this period or as soon after as possible. However, if your second dose is given later than this, you do not need to restart the vaccine. You still only need to get the second dose. However, it is important to note that the first dose did not protect as many people as were protected after the second dose, so if you are exposed to SARS-CoV-2 during the delay, you may or may not have enough immunity to prevent you from experiencing symptoms.

Can Receiving A Covid

No. Receiving a COVID-19 vaccine will not make you magnetic, including at the site of vaccination which is usually your arm. COVID-19 vaccines do not contain ingredients that can produce an electromagnetic field at the site of your injection. All COVID-19 vaccines are free from metals.

Learn more about the  in the COVID-19 vaccinations authorized for use in the United States.

How Well Do The Covid

All three COVID-19 vaccines approved for use in the U.S. work well.

mRNA vaccines: More than 9 of every 10 people vaccinated during the clinical trials were protected from disease. Likewise, a study of vaccine performance in the community also found that 9 of 10 individuals are protected. Read a summary of the study.

Adenovirus-related vaccine: While only about 6 or 7 of every 10 people vaccinated during the clinical trials were protected from disease, the study found that 8 or 9 were protected from severe disease and all were protected against hospitalization by one month after vaccination. Also, studies of the mRNA and adenovirus vaccines were done on different populations, making it difficult to compare these vaccines. Whereas all of the mRNA studies were done in the United States, the adenovirus vector vaccine studies were performed in Latin America, South Africa and the United States. Because the viral strains circulating in South Africa and Latin America were different from those circulating in the United States, its difficult to directly compare the relative efficacies.

What Is Long Covid

Long COVID, also known as COVID syndrome or long-term COVID, is a condition characterized by long-lasting symptoms related to previous SARS-CoV-2 infection. Symptoms can last for weeks or months after viral clearance and resolution of the initial infection. Examples of the types of symptoms that affected individuals report include fatigue, difficulty thinking or concentrating , headache, loss of taste or smell, dizziness, heart palpitations, chest pain, shortness of breath, cough, joint or muscle pain, anxiety, depression, or fever. Symptoms sometimes appear or worsen after physical or mental activity. The reasons for or susceptibility to these long-lasting effects remain uncertain but are being studied.

If I Have An Autoimmune Or Immune

People with immune-compromising conditions may get the COVID-19 vaccine as long as they are not in one of the following categories:

  • Severe allergy to a vaccine component
  • History of severe allergy to any vaccine or injectable medication

However, it is recommended that individuals with compromised immune systems discuss their personal risks and benefits with a healthcare provider to determine whether to receive the vaccine. Data about how well the vaccine works and its safety in immune-compromised individuals are not currently available, so it is possible that these individuals could have a lower immune response to vaccination. On the other hand, persons with these conditions may also be at higher risk of severe disease due to COVID-19. Therefore, the CDC recommended that people who are immune-compromised or taking immunosuppressive medications could receive the vaccine if they wanted as long as they do not have other contraindications.

With this said, knowing the potential for a lower immune response, if someone with an immune-compromising condition decides to get vaccinated, it will be important to get both doses  and practice other public health measures until more is known about their protection against SARS-CoV-2, the virus that causes COVID-19.Post-licensure monitoring systems, like the Vaccine Adverse Events Reporting System and the Vaccine Safety Datalink , will be used to allow  for real-time monitoring of these sub-groups.

- Advertisment -

Hot Topics

- Advertisment -

Related Articles